Men With Low Testosterone May Pay A Steeper Health Price For A High-Sugar Diet

Low Testosterone May Worsen Fructose-Related Fatty Liver Risk

Most men past 40 have heard that testosterone drops with age. What far fewer know is that declining testosterone may increase vulnerability to fat buildup in the liver, especially in men who regularly drink sodas, fruit juices, or other high-fructose beverages.

New research in mice shows the combination of low testosterone and high fructose intake does something neither condition manages on its own: a rapid acceleration of fat buildup in the liver. That finding matters for a lot of men. Roughly 5.58 million Americans between the ages of 40 and 79 currently live with both low testosterone and excessive fructose consumption at the same time. Most likely don’t realize they fall into that overlap, and few conversations about low testosterone include any discussion of liver health.

Published in the American Journal of Physiology: Endocrinology and Metabolism, the study also uncovered a previously unrecognized piece of the puzzle. Changes in gut bacteria that cause a compound called pyruvate to accumulate and promote fat buildup in liver cells.

Low Testosterone and High Fructose Are Both More Common Than Men Realize

Testosterone begins declining gradually after a man’s 30s. About 17% of men between 40 and 79 meet the clinical definition of low testosterone, with symptoms often mistaken for normal aging: fatigue, abdominal weight gain, reduced muscle tone. What rarely enters that conversation is what low testosterone does to the liver, and how diet makes it worse.

At the same time, an estimated 43% of Americans consume more sugar than health guidelines recommend. Fructose, found in sodas, energy drinks, packaged snacks, and fruit-flavored beverages, is processed almost entirely by the liver. When it arrives in excess, the liver converts it into fat. Both low testosterone and high fructose intake are recognized risk factors for fatty liver disease, a condition estimated to affect about 30% of people worldwide. Their combined effect, however, had never been directly studied until now.

What Researchers Found When Both Risk Factors Were Combined

Researchers at Osaka Metropolitan University divided male mice into six groups. Some were surgically castrated to eliminate testosterone, while others underwent a sham procedure that left hormone levels intact. Within each group, mice received plain water, a 10% fructose solution comparable to many common soft drinks, or fructose water plus antibiotics to suppress gut bacteria. After eight weeks, the results were telling.

Castration alone did not significantly increase liver fat. Fructose alone produced only a modest, borderline rise. Combining both conditions drove liver fat and cholesterol levels well beyond what either factor caused independently, and histological analysis confirmed fatty changes in the liver that were absent in the other groups.

Liver enzymes that typically signal cell damage remained normal even in the worst-affected mice. That means the liver was accumulating fat silently, at an early stage before serious or irreversible damage sets in. Early fatty liver disease often produces no symptoms at all, which is precisely what makes it easy to miss.

How Gut Bacteria Drive the Damage

One of the more revealing results came from the antibiotic-treated mice. Animals that received both castration and fructose alongside antibiotics showed substantially less liver fat than those without the drugs. Since antibiotics suppress gut bacteria, that outcome pointed directly to the microbiome as a key driver.

Analysis of the bacteria living in the gut confirmed that the combination of castration and fructose shifted gut microbial composition in ways that neither condition produced alone. Measurements of chemical byproducts in the cecum, a pouch in the gut where many bacterial compounds collect, showed that levels of a molecule called pyruvate were significantly elevated only in the combined group. Antibiotic treatment brought those levels back down.

Pyruvate sits at a metabolic crossroads. Under normal conditions, gut bacteria convert it into other compounds and clear it efficiently. In the combined condition, certain bacterial species responsible for that conversion appeared less active, allowing pyruvate to accumulate and potentially influence liver metabolism. To confirm that pyruvate could directly drive fat accumulation, the team cultured isolated mouse liver cells with pyruvate, fructose, or both. Neither compound alone caused significant fat buildup. Together, they produced a sharp, statistically significant surge in fat inside the cells. As the researchers noted, this is “the first study to investigate the effects of pyruvate on the steatosis of primary hepatocytes.”

Pyruvate’s role here is worth pausing on. It has long been studied as an energy molecule, not a driver of liver disease. If further research confirms that gut-derived pyruvate contributes to fatty liver in humans, it could point toward a new and largely overlooked target for treatment, one tied directly to the bacterial landscape of the gut.

Separately, the researchers found that gene activity inside the liver itself also changed in the combined group, with genes governing fat production and fructose processing ramping up in ways that antibiotics did not reverse. That suggests the gut-pyruvate pathway is only part of the story, and that low testosterone and fructose together alter liver function through more than one route.

For middle-aged men managing declining testosterone, this raises a question that almost never comes up in clinical settings: what role is diet playing alongside it? As the researchers put it, “risk factors for hepatic steatosis can exert a greater impact on disease development through complex mechanisms under certain conditions.” For millions of American men, that may describe their situation right now, without anyone having told them so.

---

Disclaimer: This article is based on animal research conducted in mice and has not been replicated in human clinical trials. Results should not be interpreted as medical advice. Consult a qualified healthcare provider with questions about testosterone levels, diet, and liver health.

---